Wallace E Brandt

Title: Wallace E Brandt: Innovator in Veterinary Therapeutics

Introduction

Wallace E Brandt is a notable inventor based in Kinnelon, NJ (US), recognized for his contributions to veterinary medicine. He holds a patent that addresses systemic bacterial infections in companion animals, particularly dogs. His innovative approach has the potential to improve the treatment of these infections through convenient oral administration.

Latest Patents

Wallace E Brandt's patent focuses on the therapeutic treatment of animals with oral administration of an antibacterial combination. This combination includes ormetoprim and a sulfonamide, which effectively treats systemic bacterial infections caused by both aerobic and anaerobic organisms. The patent outlines various dosage forms, such as concentrates for feed or drinking water, boluses, tablets, pastes, solutions, and suspensions for direct administration to animals. He holds 1 patent for this significant advancement in veterinary therapeutics.

Career Highlights

Brandt's career is marked by his work at Hoffmann-La Roche Inc., where he has contributed to the development of innovative treatments for animals. His expertise in veterinary medicine and pharmacology has led to advancements that benefit both pets and their owners.

Collaborations

Throughout his career, Wallace E Brandt has collaborated with notable colleagues, including Lyle J Hanson and Gianpaolo Maestrone. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of veterinary therapeutics.

Conclusion

Wallace E Brandt's contributions to veterinary medicine through his patent for treating systemic bacterial infections in companion animals highlight his dedication to improving animal health. His work continues to influence the field and offers promising solutions for pet owners and veterinarians alike.